Implantable medical device with ventricular pacing protocol including progressive conduction search

• US 20060167508A1
• Filed: 01/21/2005
• Published: 07/27/2006
• Est. Priority Date: 01/21/2005
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Boute, Willem, Rouw, Mattias
• Granted Patent: US 7,593,773 B2
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

An implantable medical device operates to promote intrinsic ventricular depolarization according to a pacing protocol. The medical device operates to promote intrinsic conduction by providing elongated AV intervals or operating in an atrial based pacing mode. Conduction checks to determine if AV conduction is present are performed on a graduated or progressive scale to facilitate intrinsic emergence.

Claims

1. A method comprising:

operating an implantable medical device with a Ventricular Pacing Protocol;

initiating a conduction check while in a dual chamber pacing mode having an AV interval at a first duration to determine if intrinsic conduction is present, the conduction check including incrementally increasing a duration of the AV interval in the dual chamber pacing mode over subsequent cardiac cycles until a maximum AV interval is reached, then operating in an atrial based pacing mode for one cardiac cycle;

operating in the atrial based pacing mode if the conduction check identifies the presence of intrinsic conduction;

operating in the dual chamber pacing mode and at the AV interval of the first duration if no intrinsic conduction is sensed during the one cardiac cycle.

2. The method of claim 1, wherein sensing intrinsic conduction during an AV interval while operating in the dual chamber mode during the conduction test will terminate the conduction test and the VPP will operate in the atrial based pacing mode.

3. The method of claim 1, wherein the conduction test will complete prior to operation in the atrial based pacing mode.

4. The method of claim 1, wherein ventricular activity is sensed to determine if intrinsic conduction is present, the ventricular activity is analyzed and if the ventricular activity is a premature ventricular contraction (PVC), the ventricular activity is ignored.

5. The method of claim 4, wherein only a first occurrence of a PVC within a predetermined window is treated as intrinsic conduction.

6. The method of claim 4, wherein the VPP limits the AV interval to a duration less than the maximum duration, but greater than the first duration if PVC are repetitively sensed.

7. The method of claim 1, wherein ventricular activity is sensed to determine if intrinsic conduction is present, the ventricular activity is analyzed and if the ventricular activity is a premature ventricular contraction, the ventricular activity is treated as intrinsic conduction.

8. An implantable medical device comprising:

means for operating an implantable medical device with a Ventricular Pacing Protocol;

means for initiating a conduction check while in a dual chamber pacing mode having an AV interval at a first duration to determine if intrinsic conduction is present and means for incrementally increasing a duration of the AV interval during the conduction check in the dual chamber pacing mode over subsequent cardiac cycles until a maximum AV interval is reached, then operating in an atrial based pacing mode for one cardiac cycle;

means for operating in the atrial based pacing mode if the conduction check identifies the presence of intrinsic conduction; and

means for operating in the dual chamber pacing mode and at the AV interval of the first duration if no intrinsic conduction is sensed during the one cardiac cycle.

9. The IMD of claim 8, wherein sensing intrinsic conduction during an AV interval while operating in the dual chamber mode during the conduction test will terminate the conduction test and the VPP will operate in the atrial based pacing mode.

10. The IMD of claim 8, wherein the conduction test will complete prior to operation in the atrial based pacing mode.

11. The IMD of claim 8, further including means for sensing ventricular activity to determine if intrinsic conduction is present and means for analyzing the ventricular activity and if the ventricular activity is a premature ventricular contraction (PVC), the ventricular activity is ignored.

12. The IMD of claim 11, wherein only a first occurrence of a PVC within a predetermined window is treated as intrinsic conduction.

13. The IMD of claim 11, wherein the VPP limits the AV interval to a duration less than the maximum duration, but greater than the first duration if PVC are repetitively sensed.

14. The IMD of claim 8, further comprising means for sensing ventricular activity to determine if intrinsic conduction is present and means for analyzing the ventricular activity and if the ventricular activity is a premature ventricular contraction, the ventricular activity is treated as intrinsic conduction.

15. A method comprising:

operating an implantable medical device (IMD) in a dual chamber pacing mode with an AV interval of a first duration;

extending the duration of the AV interval in each of a plurality of subsequent consecutive cardiac cycles until a maximum AV interval is reached; and

operating the implantable medical device in an atrial based pacing mode in a cardiac cycle immediately subsequent to the cardiac cycle with the maximum AV interval.

16. The method of claim 15, further comprising:

operating the IMD according to a VPP in the atrial based pacing mode if intrinsic conduction is sensed in the cardiac cycle immediately subsequent to the cardiac cycle with the maximum AV interval.

17. The method of claim 15, further comprising:

operating the IMD in the dual chamber pacing mode with the AV interval of the first duration if no intrinsic conduction is sensed during the cardiac cycle immediately subsequent to the cardiac cycle with the maximum AV interval.

18. The method of claim 15, further comprising operating the IMD in the dual chamber pacing mode with the AV interval at a duration intermediate to the first duration and the maximum duration in response to a premature ventricular contraction (PVC).